¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Triple Amino Acid Complex Oral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • basal complex
    ¹Ù´Úº¹ÇÕÃþ
  • circulating immune complex
    ¼øÈ¯¸é¿ªº¹ÇÕü
  • complex
    1. º¹ÇÕ 2. º¹ÇÕü 3. ÄÞÇ÷º½º
  • complex cell
    º¹ÇÕ¼¼Æ÷
  • complex compound
    º¹ÇÕÈ­ÇÕ¹°
  • complex echo pattern
    º¹Çո޾Ƹ®¸ð¾ç, º¹ÇÕ¿¡ÄÚ¾ç»ó
  • complex fracture
    º¹Àâ°ñÀý
  • complex hyperplasia
    º¹ÇÕÁõ½Ä
  • complex inheritance
    º¹ÇÕÀ¯Àü
  • complex molecule
    º¹ÇÕºÐÀÚ
  • complex odontoma
    º¹ÀâÄ¡¾ÆÁ¾
  • complex partial seizure
    º¹ÇպκйßÀÛ
  • complex position sense
    º¹ÇÕÀ§Ä¡°¨°¢
  • complex potential
    º¹ÇÕÀüÀ§
  • complex receptive field
    º¹ÇÕ¼ö¿ë¾ß
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • uric acid nephropathy
    (¢¡ urate nephropathy) ¿ä»ê¿°ÄáÆÏº´Áõ
  • acid fast organism
    Ç×»ê±Õ
  • acid radical
    »ê±â
  • acid salt
    »ê¼º¿°
  • acid-fast stain
    Ç׻꿰»ö
  • acetylsalycylic acid antiplatelet therapy
    Ç×Ç÷¼ÒÆÇ¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • oral angle
    ÀÔ²¿¸®
  • oral arch
    (¢¡palatal arch) ÀÔõÀåȰ
  • oral hypoglycemic agent
    °æ±¸Ç÷´ç°­ÇÏÁ¦
  • oral bacteriology
    ±¸°­¼¼±ÕÇÐ
  • oral bacterium
    ÀÔ¼Ó±Õ
  • oral cavity
    ÀÔ¾È, ±¸°­
  • oral cholecystography
    °æ±¸¾µ°³Á¶¿µ¼ú, °æ±¸´ã³¶Á¶¿µ¼ú
  • oral contraception
    °æ±¸ÇÇÀÓ
  • oral contraceptive
    °æ±¸ÇÇÀÓÁ¦, ¸Ô´ÂÇÇÀÓÁ¦
  • oral dependence
    ±¸°­ÀÇÁ¸
  • oral disease
    ÀÔº´, ±¸°­Áúȯ
  • oral fissure
    ÀÔ¼úÆ´»õ
  • oral floor
    ÀԾȹٴÚ
  • oral flora
    ÀԾȱչ«¸®, ±¸°­±ÕÃÑ
  • oral microbial flora
    ÀԾȹ̻ý¹°¹«¸®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • immune complex measurement
    ¸é¿ªº¹ÇÕÃ¼ÃøÁ¤
  • immune complex mediated hypersensitivity
    ¸é¿ªº¹ÇÕü¸Å°³ °ú¹Î¹ÝÀÀ
  • immune complex urticaria
    ¸é¿ªº¹Çյε巯±â
  • immune complex vasculitis
    ¸é¿ªº¹ÇÕüÇ÷°ü¿°
  • immune complex vasculitis
    ¸é¿ªº¹ÇÕü¼º Ç÷°ü¿°(Øóæ¹ÜÜùêô÷àõ úìηæú)
  • immune complex-mediated
    ¸é¿ªº¹ÇÕü¸Å°³°ú¹ÎÁõ(Øóæ¹ÜÜùêô÷ØÚ˿ΦÚÂñø)
  • inner complex salt
    ³»Âø¿°(Ò®ó¹ç¤).
  • pore complex
    ÇÙ±¸¸Ûº¹ÇÕü
  • primary complex
    Ãʱ⺯ȭ±º(ôøÑ¢Ü¨ûùÏØ).
  • primary complex
    Ãʱ⺯ȭ±º(ôøÑ¢Ü¨ûùÏØ)
  • primary inoculation complex
    ¿ø¹ß¼º Á¢Á¾ º¹ÇÕü
  • prothrombin complex concentrates
    ÇÁ·ÎÆ®·Òºó º¹ÇÕ ³óÃà(¹°)
  • 3,5-dinitrobenzoic acid
    3,5-µð´ÏÆ®·Îº¥Á¶»ê
  • 3-hydroxybutyric acid
    3-È÷µå·Ï½Ã³«»ê
  • 5-hydroxyindoleacetic acid
    5-È÷µå·Ï½ÃÀε¹¾Æ¼¼Æ®»ê, 5-È÷µå·Ï½ÃÀε¹ÃÊ»ê
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ÀÀ°í°áÇÕü
  • antigen-antibody complex
    Ç׿ø-Ç×üº¹ÇÕü
  • antigen-antibody complex, soluble
    ¼ö¿ë¼º Ç׿ø-Ç×üº¹ÇÕü
  • avian leukosis complex
    Á¶·ù¹éÇ÷±¸Áõ¹ÙÀÌ·¯½ºº¹ÇÕü
  • avian leukosis complex
    Á¶Çü¹éÇ÷Áõ.
  • avian leukosis complex
    Á¶Çü¹éÇ÷Áõ.
  • avian leukosis complex virus
    Á¶·ù ¹éÇ÷±¸Áõ ¹ÙÀÌ·¯½º±º(ðè×¾ÛÜúìÜ»¡­ÏØ).
  • basal complex basal lamina
    ¹Ù´Úº¹ÇÕÃþ
  • calcarine complex =hippocampus minor
    ¼ÒÇØ¸¶(á³ú­Ø©).
  • castration complex
    °Å¼¼ ÄÄÇ÷º½º
  • central renal echo complex
    ½ÅÁ᫐ (ãìñéãý) ¿¡ÄÚ º¹ÇÕü (ÜÜùêô÷), ½ÅÁ᫐ (ãìñé
  • central renal echo complex
    ½ÅÁ᫐ ¿¡ÄÚ º¹ÇÕü
  • circulating immune complex (CIC)
    Ç÷Á߸鿪º¹ÇÕü
  • complex
    ÄÞÇ÷º½º, º¹ÇÕü(ÜÜùêô÷).
  • complex
    ÄÄÇ÷º½º, º¹ÇÕü(ÜÜùêô÷)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • sulfur amino acid
    Ȳ(üÜ)¾Æ¹Ì³ë»ê(ß«)
  • uncharged polar amino acid
    ¹«ÀüÇÏ(Ùíï³ùÃ) ±Ø¼º(пàõ)¾Æ¹Ì³ë»ê(ß«)
  • uncoded amino acid
    ¹«(Ùí)ÄÚµ· ¾Æ¹Ì³ë»ê(ß«)
  • activated complex
    Ȱ¼ºº¹ÇÕ¹° (üÀàõÜÜùêÚª)
  • antigen-antibody complex
    Ç׿øÇ×ü º¹ÇÕü(ù÷ê«ù÷ô÷ ÜÜùêô÷)
  • Arrenius complex
    ¾Æ·¹´Ï¿ì½º º¹ÇÕü(ÜÜùêô÷)
  • B complex
    B º¹ÇÕü(ÜÜùêô÷)
  • binary complex mechanism
    À̼ººÐ º¹ÇÕü ±âÀü(ì£à÷Ý ÜÜùêô÷Ѿï®)
  • bridge complex
    ±³»óº¹ÇÕü(ÎéßÒÜÜùêô÷)
  • central complex
    Á᫐ º¹ÇÕü(ñéãýÜÜùêô÷)
  • CF0-CF1 complex
    CF0-CF1 º¹ÇÕü(ÜÜùêô÷)
  • charge transfer complex
    ÀüÇÏÀ̵¿ º¹ÇÕü(ï³ùÃì¹ÔÑÜÜùêô÷)
  • closed-promoter complex
    ´ÝÈùÇÁ·Î¸ðÅÍ º¹ÇÕ¹°(ÜÜùêÚª)
  • coenzyme Q-cytochrome c reductase complex
    º¸È¿¼Ò(ÜÍý£áÈ) Q¡¤»çÀÌÅäÅ©·Ò C ¸®´ÚÅ×À̽º (ÔÒ) complex III
  • complex
    º¹ÇÕ¹°(ÜÜùêÚª)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
PAA partial agonist activity; phenylacetic acid; phosphonoacetic acid; physical abilities analysis; plas...
TSI   1) Thyroid Stimulating Immunoglobulin
  2) Triple Sugar Iron agar
FACIT fibril-associated collagen with interrupted triple helices
TCABG triple coronary artery bypass graft
TCAG triple coronary artery graft
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
3 APS 3 amino propane sulphonic acid
GABA 4-Amino-n-butyric acid
5-ASA 5 amino salicylic acid
6-APA 6-Amino penicillanic acid
7-ACA 7-amino cephalosporanic acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • vesitibular nuclear complex
    ÀüÁ¤½Å°æ ÇÙ
  • vitamin B complex
    ºñŸ¹ÎB º¹ÇÕü
  • antro-oral opening
    »ó¾Çµ¿ õ°ø
  • character oral
    ±¸°­±â ¼º°Ý
  • fecal-oral
    ¹è¼³¹°À» ÅëÇÑ
  • focal oral mucitis
    ±¹¼Ò¼º ±¸°­ Á¡¾×Áõ
  • maladaptive oral habit
    ¼øÀÀ ºÒ·®¼º ±¸°­ ½À°ü
  • naso- ÄÚ¿ÍÀÇ °ü°è¸¦ ³ªÅ¸³»´Â Á¢µÎ¾î.

    naso-oral

    ºñ ±¸°­ÀÇ
  • oral acute pseudomembranous candidiasis
    ¾Æ±¸Ã¢
  • oral alveolar mucosa
    ±¸°­ Ä¡Á¶ Á¡¸·
  • oral anticoagulant
    °æ±¸ Ç×ÀÀÇ÷ ¾à
  • oral aphthae
    ±¸³» ¾ÆÇÁŸÁõ
    ±¸°­ Á¡¸·¿¡ ³ªÅ¸³ª´Â Àû»ö, ȸ»öÀÇ ÀÛÀº ¹ÝÁ¡À̳ª ±Ë¾ç.
  • oral arch
    ÀÔ±Ã, ±¸°³±Ã
  • oral cancer
    ±¸°­ ¾Ï
    Àüü ¾Ï ¹ß»ý ºóµµ¿¡¼­ ¾à 3¡­4%¸¦ Â÷ÁöÇÏ´Â ±¸°­ ¾ÏÀº Çô, »´, Ä¡ÁÖÁ¶Á÷, ¶Ç´Â ±¸ÀεÎÀÇ ¾î´À ºÎÀ§¿¡µµ ħ¹üÇÒ ¼ö ÀÖ´Ù. ÀÌ´Â ±¸°­ ³»ÀÇ ¹ß»ý À§Ä¡¿¡ µû¶ó ´Þ¶óÁö±â´Â ÇÏÁö¸¸ ´ë°³ ¿©ÀÚº¸´Ù´Â ³²ÀÚ¿¡°Ô¼­ ¾à 2~6¹è ¸¹ÀÌ ¹ß»ýÇÏ¸ç ¿ì¸® ³ª¶ó¿¡¼­´Â 1³â¿¡ ¾à õ ¸í ³»Áö ÀÌ Ãµ¸íÀÇ »õ·Î¿î ±¸°­ ¾Ï ȯÀÚ°¡ ¹ß»ýÇϱ⠶§¹®¿¡ ±¸°­ ¾ÏÀ¸·Î Åõº´ ÁßÀΠȯÀÚ¸¸µµ ¼ö ¸¸ ¸í¿¡ À̸¥´Ù. 1996³â¿¡ ½ÃÇàÇÑ ÈÄÇ⼺ ¿¬±¸¿¡ ÀÇÇϸé Àüü ±¸°­ ¾Ï ȯÀÚÀÇ Æò±Õ 5³â »ýÁ¸À²Àº ¾à 46%·Î ¹Ý ÀÌ»óÀÇ È¯ÀÚ°¡ 5³â À̳»¿¡ »ç¸ÁÇÏ´Â °ÍÀ¸·Î Á¶»çµÈ¹Ù ÀÖ´Ù. ±¸°­ ¾ÏÀÇ À¯º´·üÀº ¿¬·É Áõ°¡¿Í °ü·ÃÀÌ ÀÖ´Ù. 40¼¼ ÀÌÈÄ¿¡ ¹ß»ý·üÀÌ ±ØÀûÀ¸·Î Áõ°¡Çϱ⠽ÃÀÛÇÏ¿© 60¼¼ÀÇ ¿¬·É¿¡¼­ ÀÏÁ¤ÇÑ À¯Áö °î¼±À» Çü¼ºÇÑ´Ù. ¾î¶² ¿ä¼Ò°¡ ±¸°­ ¾Ï ¹ß»ý¿¡ °¡Àå Å« ¿µÇâÀ» ³¢Ä¡´Â°¡¿¡ ´ëÇÑ ¹®Çå ¿¬±¸¿¡¼­ ´ã¹è¿Í ¼úÀÌ ¸ðµç ±¸°­ ¾ÏÀÇ 75%¸¦ ¾ß±âÇØ ÀÌ Áúȯ¿¡ °¡Àå Å« ¿µÇâÀ» ¹ÌÄ¡´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù. Èí¿¬°ú °úÀ½ÀÌ °¢°¢ ±¸°­ ¾ÏÀÇ À§Ç輺À» Áõ°¡½ÃŰ´Â ¹Ý¸é, ±×µéÀÇ »óÇÕÈ¿°ú´Â ±× ¸î ¹èÀÎ °ÍÀ¸·Î ³ªÅ¸³ª¼­ °ñÃÊ¿¡ ¾ËÄÝ Áßµ¶À̶ó¸é Á¤»óÀÎÀÇ ¾à 30¹è ÀÌ»ó ÀÌȯÀ²ÀÌ ³ô¾ÆÁø´Ù. ±¸°­ ¾ÏÀÇ ÈçÇÑ Àü±¸ Áõ»óÀ¸·Î ¾Ë·ÁÁø ¹é¹ÝÁõÀº ±¸°­ Á¡¸·¿¡ Èò ¹éŸ¦ º¸ÀÌ´Â º´º¯À¸·Î ÀÌ ÁúȯÀÌ ¾ÏÁ¾À¸·Î ÁøÇàµÉ È®·üÀº 0.1%~36%ÀÇ ¸Å¿ì ´Ù¾çÇÑ ÆíÂ÷·Î º¸°íµÇ°í ÀÖÀ¸³ª ÀϹÝÀûÀ¸·Î´Â 10Áõ·Ê Áß 1Áõ·Ê°¡ ÀÌÇàµÇ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. Àß ÀûÇÕµÇÁö ¾Ê´Â Ʋ´Ï³ª ¿À·¡ »ç¿ëÇÏ¿© ¸¶¸ðµÇ°í ³¯Ä«·Î¿öÁø ±Ý°ü µî¿¡ ÀÇÇÏ¿© Çù Á¡¸·À̳ª Çô, ¹«Ä¡¾Ç Ä¡Á¶Á¤ Á¡¸· µî¿¡ ¹ß»ýµÇ´Â ±Ë¾ç¼º º´º¯Àº Á¾±¹¿¡´Â ±¸°­ ¾ÏÀ¸·Î ÀüÀ̵DZ⠽¬¿î °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ¾î ÁÖ±âÀûÀÎ Ä¡°ú °ËÁøÀÌ ÇÊ¿äÇÏ´Ù. ±¸°­ ¾ÏÀÇ À§Çè ¿ä¼Ò Áß¿¡´Â À¯ÀüÀû ¿ä¼Òµµ ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù. ƯÁ¤ Áý´Ü Áß¿¡´Â ¾ÏÀ» °¡Áö°í ÀÖ´Â °¡Á·ÀÌ ÀÖÀ¸¸é ±¸°­ ¾ÏÀÇ ¹ß»ý À§Ç輺ÀÌ ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. Èí¿¬°ú À½ÁÖ°¡ ±¸°­ ¾Ï ¹ß»ý¿¡ °¡Àå Áß¿äÇÑ ¿äÀÎÀ̱⠶§¹®¿¡ Áß´ÜÇϰųª ÃÖ¼ÒÇÑ ÁÙÀÌ´Â °ÍÀÌ ¸Å¿ì Áß¿äÇÏ´Ù. °Ç°­ÇÑ ½Ä»ýȰÀº ±¸°­ ¾ÏÀ» ¿¹¹æÇÒ ¼ö ÀÖ´Ù. ½Å¼±ÇÑ °úÀÏÀ̳ª ³ì»ö ä¼Ò´Â ±¸°­ ¾Ï ¹ß»ý·üÀ» °¨¼Ò½Ãų ¼ö ÀÖ°í, ÀÌ´Â ºñŸ¹Î A, C, E°¡ ÇÔÀ¯µÈ À½½ÄÀÌ ¿¹¹æ È¿°ú¸¦ °®´Â´Ù´Â »ç½ÇÀ» µÞ¹ÞħÇÑ´Ù. ±¸°­ Á¡¸·À» µ¥ÀÏ Á¤µµÀÇ ¶ß°Å¿î À½½ÄÀ̳ª ÀڱؼºÀÇ À½½ÄÀº ÇÇÇϵµ·Ï ÇÏ´Â °ÍÀÌ ÁÁ´Ù. HPVÀÇ ¹ßÇöÀ̳ª P53 À¯Àü ÀÎÀÚÀÇ º¯À§¿Í °°Àº ƯÁ¤ À¯ÀüÇÐÀû ¶Ç´Â Ãʱ⠼¼Æ÷ º¯È­°¡ ±¸°­ ¾Ï°ú °ü·ÃÀÌ ÀÖ´Ù´Â ¹ß°ßÀº ÃÖ±Ù ÁÖ¸ñ¹Þ°í ÀÖ´Â ¿¬±¸ÀÌ´Ù. °¡±î¿î ¹Ì·¡¿¡´Â ±¸°­ ¾ÏÀÇ À§Ç輺ÀÌ ³ôÀº ȯÀÚÀÇ ±¸°­ Á¡¸·À» ÁÖ±âÀûÀ¸·Î °Ë»çÇϰųª Ãʱ⠼¼Æ÷ º¯È­¸¦ º¸À̴ ȯÀÚ¸¦ ÀÎÁöÇÏ´Â °ÍÀÌ °¡´ÉÇÒ °ÍÀÌ´Ù. ±¸°­ ¾ÏÀÇ Á¶±â ¹ß°ß°ú Ä¡·á¸¦ À§ÇÑ À¯¿ëÇÑ ±â¼úÀÇ °³¹ßÀº ÀÌ ºÐ¾ß¿¡¼­ ±â´ëµÈ´Ù. ±¸°­ ¾ÏÀº ¹ß»ý Ãʱ⿡´Â º°´Ù¸¥ Áõ»óÀ» º¸ÀÌÁö ¾Ê°í ¼­¼­È÷ ÁøÇàµÇ±â ¶§¹®¿¡ Á¶±â ¹ß°ßÀÌ ¹«Ã´ ¾î·Æ´Ù. ±¸°­ ¾Ç¾È¸é ¿µ¿ªÀÇ ¾ÏÀÇ Á¶±â ¹ß°ßÀº ¿©·¯ °¡Áö ÀÓ»óÀûÀÎ ¹ß°ßÀÌ ±âÃʰ¡ µÇ´Âµ¥ Ãʱ⿡´Â ´ë°³ ºÓÀº È«¹ÝÁõÀ» º¸À̸ç Á¡¸·ÀÌ °ÅÄ¥¾îÁö°í ¾à°£ À¶±âµÇ³ª À̶§´Â ¿°Áõ¼º º´¼Ò¿Í ºñ½ÁÇÏ¿© °¨º°ÀÌ °ï¶õÇÏ´Ù. ÀÌÈÄ ÁøÇàµÇ¾î ÀԾȿ¡ Èò ¸·ÀÌ »ý±â°Å³ª ÀÔ¾ÈÀÌ Çæ¾î ±Ë¾çÀÌ »ý±â°í º¸¸§ ÀÌ»ó ³´Áö ¾Ê°í Áö¼ÓµÇ´Â °æ¿ìµµ ÀÖ´Ù. ÀԾȿ¡ ¸¸¼ºÀûÀ¸·Î ¹é»ö º´¼Ò°¡ ÀÖ´Â °æ¿ì, ¸ñ¿¡ ¸Û¿ïÀÌ »ý±â°í ¾ø¾îÁöÁö ¾Ê´Â °æ¿ì ±¸°­ ¾ÏÀÌ ÀǽɵǹǷΠÁ» ´õ ¼¼¹ÐÇÑ Áø´ÜÀ» ¹Þ¾Æº¸´Â °ÍÀÌ ±ÇÀåµÇ¸ç Á¶±â Áø´Ü ½Ã »ýÁ¸À²Àº ÇöÀúÇÏ°Ô ³ô¾ÆÁö°Ô µÈ´Ù. ±¸°­ ¾Ï Ä¡·á ¹æ¹ýÀº ´ëÇ¥ÀûÀ¸·Î ¿Ü°úÀû ¼ö¼ú, ¹æ»ç¼± ¿ä¹ý, Ç×¾Ï ¿ä¹ýÀ¸·Î ÀÌ·ç¾îÁö¸ç ´Üµ¶À¸·Î ¶Ç´Â º¹ÇÕÀûÀ¸·Î ½ÃÇàµÈ´Ù. ÃÖ±Ù¿¡ ¸é¿ª ¿ä¹ý, ±¤ ¿¡³ÊÁö ¿ä¹ý µîÀÌ °³¹ßµÇ°í ÀÖÀ¸³ª ¾ÆÁ÷ ÀÓ»óÀûÀ¸·Î Ȱ¹ßÈ÷ ÀÌ¿ëµÇ°í ÀÖÁö´Â ¸øÇÏ´Ù. ±¸°­ ¾Ç¾È¸é ºÎÀ§ÀÇ Á¾¾çÀÇ ÀýÁ¦ ½Ã¿¡´Â Åë»ó ¾Ç¾È¸é ºÎÀ§ÀÇ °á¼ÕÀ¸·Î ±â´É Àå¾Ö¿Í ¾È¸ð ÃßÇü µîÀÇ ½É¹ÌÀûÀÎ ¼Õ»ó°ú ÀÌ¿¡ µû¸¥ Á¤½Å ½É¸®Àû ¹®Á¦Á¡À» ¾ß±âÇÒ ¼ö ÀÖ´Ù. ±¸°­ ¾Ï ÀýÁ¦¼ú ÈÄ ¾Ç°ñ ¹× ¿¬Á¶Á÷ °á¼ÕÀÌ ÀÖ´Â °æ¿ì¿¡ ¾Ç°ñ Àç°ÇÀ» ´Ü¼øÈ÷ º¹¿øÀ̶ó´Â °³³äÀ» ¶°³ª ½É¹ÌÀûÀ̰í ÀúÀÛ ±â´ÉÀÇ È¸º¹À̶ó´Â Â÷¿ø¿¡¼­ Àç°ÇÇÏ¿© »çȸÀûÀ¸·Î º¹±ÍÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù.
  • oral cavity
    ±¸°­
    ±¸°­Àº ÀÎü »ý¸í Çö»óÀ» À¯ÁöÇϱâ À§ÇÏ¿© À½½Ä¹°À» ¼·ÃëÇÏ´Â º»´ÉÀûÀÎ ÀúÀÛ ±â´ÉÀ» ÇÏ°í ¿¬ÇϽÃŰ¸ç ¹ßÀ½ ±â´ÉÀ» µµ¸ðÇÏ´Â ¼ÒÈ­±â °èÅëÀÇ Ã¹ °ü¹®ÀÌ´Ù. Á¦ÀÏ ¾Õ¿¡´Â ÀÔ¼ú°ú Ä¡¿­, »óºÎ¿¡´Â ±¸°³·Î ºñ°­°ú °æ°è¸¦ ÀÌ·ç¸ç Ãø¹æÀ¸·Î´Â ÇùºÎ·Î ¸·¾ÆÁø´Ù. ¶ÇÇÑ ÇϹ濡´Â Çô¿Í ¿¬Á¶Á÷ÀÌ ±¸°­Àú¸¦ ÀÌ·é´Ù. ÈĹæÀ¸·Î ¸ñÁ¥ ¹× Àεµ¿Í À̾îÁö¸ç ÈÄÃø¹æÀ¸·Î´Â Æíµµ¼±ÀÌ ÀÖ´Ù. ÇÑ ¸¶µð·Î ±¸°­Àº Àΰ£ÀÇ ¿©·¯ ±âÁö ¿å±¸¸¦ ÃæÁ·½ÃŰ´Â ±â°üÀÌ¸ç ¹°¸®Àû, ±â°èÀû, È­ÇÐÀû °¡±ØÀ» °¡Àå ½ÉÇÏ°Ô ¹Þ´Â ±â°üÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
excitatory amino acid antagonists Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.
(12 Dec 1998)
1-carbamoyl-L-amino acid amidohydrolase <enzyme> From bacillus stearothermophilus; amino acid sequence given in first source
Registry number: EC 3.5.1.-
Synonym: carbamoyl l-aa amidohydrolase, n-carbamyl-l-amino acid amidohydrolase
(26 Jun 1999)
alpha-keto acid dehydrogenase complex See: alpha-keto acid dehydrogenase.
Anaerobic dehydrogenase, an enzyme (usually a pyridinoenzyme) catalyzing the transfer of hydrogen from some metabolite to some acceptor molecule (e.g., NAD+, cytochrome) other than oxygen; e.g., lactate dehydrogenase's, isocitrate dehydrogenase's, and others in EC class 1, excluding those listed under aerobic dehydrogenase.
(05 Mar 2000)
fatty acid synthase complex The multienzyme complex that catalyses the formation of palmitate from acetylcoenzyme A, malonylcoenzyme A, and NADPH.
(05 Mar 2000)
fatty acid synthetase complex <enzyme> Registry number: EC 6.-
(12 Dec 1998)
administration, oral The giving of drugs, chemicals, or other substances by mouth.
(12 Dec 1998)
amino- <prefix> Prefix denoting a compound containing the radical, -NH2.
Origin: an(monia) + in(e) + -o-
(05 Mar 2000)
amino acids Organic compounds that generally contain an amino (-nh2) and a carboxyl (-cooh) group. Twenty alpha-amino acids are the subunits which are polymerised to form proteins.
(12 Dec 1998)
amino acids, branched-chain Amino acids which have a branched carbon chain.
(12 Dec 1998)
amino acids, cyclic A class of amino acids characterised by a closed ring structure.
(12 Dec 1998)
amino acids, peptides, and proteins Amino acids and chains of amino acids connected by peptide linkages.
(12 Dec 1998)
amino acyl-tRNA ligases <enzyme> Any of the group of ligases that catalyses the ATP-driven formation of a bond between an amino acid and a trna, activating the amino acids as a step in protein synthesis. Individual enzymes are highly specific for one amino acid and for any trna corresponding to that amino acid.
Registry number: EC 6.1.1.
(12 Dec 1998)
amino alcohols Compounds possessing both a hydroxyl (-oh) and an amino group (-nh2).
(12 Dec 1998)
amino group <biochemistry> An -NH2 group. Organic compounds which have this group are called amines.
(09 Oct 1997)
amino sugar <biochemistry> Monosaccharide in which an OH group is replaced with an amino group, often acetylated. Common examples are D galactosamine, D glucosamine, neuraminic acid, muramic acid. Amino sugars are important constituents of bacterial cell walls, some antibiotics, blood group substances, milk oligosaccharides and chitin.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • gallic acid
    °¥»ê
  • glacial acetic acid
    ºùÃÊ»ê
  • glutamic acid
    ±Û·çŸ¹Î»ê
  • hyaluronic acid
    È÷¾Ë·ç·Ð»ê (»ê¼º´ç·ù)
  • hydriodic acid
    ¿ÁÈ­ ¼ö¼Ò»ê
  • hydrochloric acid
    ¿°»ê
  • hydrocyanic acid
    ½Ã¾ÈÈ­ ¼ö¼Ò»ê;û»ê
  • hydrofluoric acid
    ºÒÈ­ ¼ö¼Ò»ê
  • hypochlorous acid
    Â÷¾Æ¿°¼Ò»ê
  • hypophosphoric acid
    Â÷Àλê
  • hypophosphorous acid
    Â÷¾ÆÀλê
  • indoleacetic acid
    Àε¹ÃÊ»ê(½Ä¹°ÀÇ ¼ºÀå È£¸£¸ó)
  • inosinic acid
    À̳ë½Å»ê
  • iodic acid
    ¿ä¿Àµå»ê
  • isonicotinic acid hydrazide
    (¾à)À̼ҴÏÄÚÆ¾»ê ÇÏÀ̵å¶óÁöµå(°áÇÙ Ä¡·áÁ¦)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á